Where innovative Medical Go-To-Market Success is the rule! 

Want to Learn or See More? Click here

Synergistic Marketing, founded in 1990 by Mark Lutvak, is a successful, growing and profitable sales and marketing contracting firm and consultancy. We are dedicated to serving Small Emerging businesses that own or possess Medical Technology or Medical Device IP. We support our clients with a go-to-market strategy that takes advantage of our extensive network of medical industry companies as well as our extensive list of contacts who are our Corporate Partners.

Want to Learn or See More? Click here

 

Medical Technology and Device News Title

  • July 21, 2016:

    A new research funding agreement between the Juvenile Diabetes Research Foundation (JDRF) and Sernova, a clinical-stage regenerative medicine biotech, aims to address people with severe type 1 diabetes (T1D) who are hypoglycemia unaware. They are at a higher risk of acute life threatening consequences that can lead to coma and death following an insulin injection that reduces blood glucose to dangerously low levels. The funding will advance human clinical trials of Sernova’s novel cell macroencapsulated implantable and scalable Cell Pouch System (CPS) with the hope to improve the quality of life and overall outcomes for these patients.Full Story

  • July 21, 2016:

    A collaborative effort between the University of Maryland Medical Center and Harpoon Medical of Baltimore is designed to provide a minimally invasive surgical solution for degenerative mitral regurgitation. Rather than opening the chest, surgery utilizing the Harpoon device enters the heart through a mini-thoracotomy on the left side of the torso, right below the breast. Thus eliminating the need to open the chest cavity and stop the heart beating..Full Story

  • July 21, 2016:

    New findings published by a team of researchers led by Dr. Andres Lozano at the Krembil Neuroscience Centre (KNC) of Toronto Western Hospital (TWH) have provided further insight into the effects of Deep Brain Stimulation (DBS) in the treatment of Alzheimer’s disease. The use of DBS appears to slow cognitive decline and improve the brain’s ability to metabolize glucose.Full Story

  • July 15, 2016:

    A study published in the Journal of Pain Research finds a safe and effective drug-free treatment option for chronic back pain sufferers called spinal cord stimulation using low-voltage electrical stimulation to the spine to block the feeling of pain, via a small device implanted in the body.Full Story

  • July 15, 2016:

    Tandem Diabetes Care, manufacturer of the t:slim, t:slim G4 and t:flex Insulin Pumps, has received U.S. Food and Drug Administration (FDA) clearance for the Tandem Device Updater, a Mac and PC-compatible tool for the remote update of Tandem insulin pump software which will be used to update t:slim Insulin Pump software of in-warranty pumps purchased before April 2015.Full Story

  • July 15, 2016:

    The first commercial surgery using Synthetic Cartilage Implant (SCI) took place at the University of Rochester Medical’s Sawgrass Surgery Center. The SCI is specifically designed to help patients experiencing arthritis at the base of their big toe and eliminates the need for screws and plates in the ailing toe which require weeks of recovery before patients can put weight on the mended toe.cientists.Full Story

  • June 22, 2016:

    Scientists from The University of Texas Health Science Center at Houston (UTHealth) and The University of Texas MD Anderson Cancer Center reported finding an obesity-induced switch, chemokine CXCL1, a signaling molecule that regulates cell trafficking. When the investigators blocked the switch in mouse models, the obesity-induced progression of prostate cancer slowed..Full Story

  • June 22, 2016:

    Sanofi, Langland and Mendor devloped a treatment method that is a patient-centric online clinical trial platform integrated with Mendor’s 3G-enabled wireless blood glucose meter in a completely remote clinical trial setting. Sixty patients — all recruited through Facebook — participated in the study with final results of a remote online Phase IV clinical trial for diabetes being successful.Full Story